Abstract:
This study evaluated trends in Medicare reimbursement for commonly performed breast oncologic and reconstructive procedures. Average national relative value units (RVUs) for physician-based work, facilities, and malpractice were collected along with the corresponding conversion factors for each year. From 2010 to 2021, there was an overall average decrease of 15% in Medicare reimbursement for both breast oncology (-11%) and reconstructive procedures (-16%). Based on these findings, breast and reconstructive surgeons should advocate for reimbursement that better reflects the costs of their practice.
摘要:
这项研究评估了通常进行的乳腺肿瘤和重建手术的医疗保险报销趋势。以医生为基础的工作的平均全国相对价值单位(RVU),设施,并收集了每年的渎职行为以及相应的转换因子。从2010年到2021年,乳腺癌(-11%)和重建程序(-16%)的医疗保险报销总体平均下降15%。基于这些发现,乳房和重建外科医师应提倡更好地反映其执业成本的报销。